Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-24 @ 5:08 PM
NCT ID: NCT04622150
Eligibility Criteria: Patients receiving care at the Nord Center, MetroHealth system, and other not-for-profit health systems. Inclusion Criteria: 1. Participants will have a diagnosis of Bipolar Disorder Type I or Type II determined by the Structured Clinical Interview for DSM-5 patient version (SCID-P). 2. Have had BD for at least two years duration 3. Have received treatment with at least one evidence-based medication to stabilize mood for at least six months (lithium, anticonvulsant, or antipsychotic mood stabilizer) 4. Yes to either of the following questions: 1. Do you ever have any trouble taking all of your medications? Or 2. Do you ever try to cope on your own without medication? 5. a BPRS ≥ 36 or YRMS ≥8 or MADRS ≥8 6. Be able to participate in psychiatric interviews and give written informed consent 7. Have their own cellular phone in order to receive text messages as part of the intervention Exclusion Criteria: 1. Unable or unwilling to participate in psychiatric interviews. This will include individuals, who may be too psychotic to participate in interviews/rating scales 2. Unable or unwilling to give written, informed consent to study participation 3. Individuals who participated in Phase 1 of the study 4. Children under the age of 18 5. Individuals at high risk for suicide who cannot be safely managed in their current treatment setting
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 89 Years
Study: NCT04622150
Study Brief:
Protocol Section: NCT04622150